Center for Targeted Therapeutics and Translational Nanomedicine (CT³N)

The CT³N invites PENN and CHOP researchers to submit competitive proposals for Pilot Grants by July 31, 2020. The goal of these Pilot Grants is to support early‐stage experimental preclinical studies in targeted therapeutics and thus assist investigators in obtaining key data to seek extramural funding. Proposals will be evaluated based on their relevance to CT³N’s areas of interest, the interdisciplinary and collaborative character (including use of PENN and CHOP core facilities, such as for instance the Chemical and Nanoparticle Synthesis Core), and innovation and translational potential. The grants will be for $40,000 for one year, starting September 1, 2020.

Please refer to the ITMAT Funding Opportunities page with detailed grant instructions and templates.

http://www.itmat.upenn.edu/funding.html

NIH Funding Opportunities and Notices 

NIH funding - search page